Stock Information
Stock Symbol: BHST
Stock Exchange: NASDAQ
Company Name: BioHarvest Sciences Inc.
Sector: Biotechnology / Health & Wellness
Technology: Botanical Synthesis
Business Focus: Plant-based molecule development, nutraceutical products, Botanical Synthesis technology and contract development and manufacturing services.
Analysis Basis: This BHST analysis uses the supplied 1-minute chart, EMA20, EMA50, EMA100, EMA200, RSI, RVOL, CMF, buy-to-sell pressure, breakout structure, support, resistance and displayed price targets.
Quick Technical Snapshot
$1.73
Current Chart Price
$1.73
Visible Current High
$1.39
Visible Major Low
50 / 100
Breakout Score
- Displayed Open: $1.68
- Displayed High: $1.73
- Displayed Low: $1.68
- Displayed Close: $1.73
- Displayed Candle Change: approximately +1.76%
- Current Price: $1.73
- Visible Major Low: $1.39
- Recovery Stage: 4 / 5
- Breakout Score: 50 / 100
- Bottom Score: 25 / 100
- RSI: 83.9
- RVOL: approximately 0.1×
- CMF: approximately +0.45
- Buy / Sell Ratio: approximately 1.0×
- Last Bottom: $1.46
- Breakout Midpoint: $2.25
- Breakout Stop: $2.18
- Breakout Price: $1.70
- Displayed Target 1: $2.34
- Displayed Target 2: $2.43
- Required Volume: approximately 687
- Displayed Breakout Distance: 0.00%
EMA Recovery Stage: 4 / 5
The supplied BHST dashboard places the stock at Stage 4 of 5.
The chart describes the current condition as a major directional recovery.
Price has successfully recovered above:
- EMA20
- EMA50
- EMA100
- EMA200
The remaining technical condition is moving-average alignment.
The dashboard shows that the price recovery is complete, but the EMA ordering has not yet completed its bullish structure.
Key EMA Levels
$1.56
EMA20
$1.51
EMA50
$1.51
EMA100
$1.56
EMA200
BHST is currently trading near $1.73, well above the major moving averages visible on the chart.
The supplied dashboard shows:
- EMA20: approximately $1.56
- EMA50: approximately $1.51
- EMA100: approximately $1.51
- EMA200: approximately $1.56
The $1.51-$1.56 region therefore forms a significant technical support cluster beneath the current price.
Breakout Level: $1.70
The supplied dashboard identifies $1.70 as the primary breakout price.
BHST is currently trading near $1.73, placing the stock above that level.
This means the initial breakout condition has been triggered according to the chart.
The next test is whether BHST can hold above $1.70 rather than quickly falling back below the breakout zone.
Immediate Breakout Support: $1.70
Because the stock has just moved through $1.70, this level becomes the most important immediate support reference.
A breakout level often becomes support if buyers successfully defend the move.
Repeated trading above $1.70 would improve the probability that the breakout remains active.
BHST Support, Resistance and Price Targets
Support Levels
- $1.70 — primary breakout level
- $1.68 — current candle low
- $1.60 — psychological support
- $1.56 — EMA20 / EMA200 area
- $1.51 — EMA50 / EMA100 area
- $1.46 — last bottom reference
- $1.39 — major visible chart low
Resistance Levels
- $1.73 — immediate current high
- $1.75 — psychological resistance
- $1.80 — next psychological level
- $2.00 — major psychological resistance
- $2.18 — displayed model reference
- $2.25 — displayed breakout midpoint
- $2.34 — displayed target 1
- $2.43 — displayed target 2
Technical Roadmap
- Current Price: $1.73
- Breakout: $1.70
- Immediate Resistance: $1.73-$1.75
- Next Zone: $1.80
- Major Psychological Level: $2.00
- Displayed Higher Targets: $2.34 / $2.43
RSI: 83.9 – Extreme Momentum
The supplied dashboard shows RSI near 83.9.
This indicates extremely strong short-term momentum, but it also places BHST well into technically overbought territory.
An RSI above 70 does not guarantee that a stock will decline. Strong momentum stocks can remain overbought during powerful continuation moves.
However, an RSI above 80 substantially increases the possibility of:
- Short-term profit taking.
- Sharp intraday volatility.
- Temporary consolidation.
- A pullback toward breakout support.
The ideal continuation would involve price holding above $1.70 while RSI gradually cools without a major price breakdown.
Relative Volume – RVOL: 0.1×
The dashboard shows RVOL near 0.1×.
This is the largest weakness in the current BHST setup.
Despite the sharp price move, relative trading volume remains low compared with the model's baseline.
A low-volume breakout can be less reliable than a breakout supported by strong market participation.
For stronger confirmation, BHST would ideally show a substantial increase in RVOL while remaining above $1.70.
CMF Money Flow: +0.45
The supplied dashboard shows CMF near +0.45.
This is a notably strong positive reading.
Positive CMF indicates that the underlying price-volume relationship is currently favoring accumulation rather than distribution.
The combination of positive CMF and price above all four major EMAs is one of the strongest features of the current setup.
Buy / Sell Ratio: 1.0×
The dashboard displays a buy-to-sell ratio near 1.0×.
This indicates that measured buying pressure and selling pressure are relatively balanced.
This is weaker than the price action itself might suggest.
A move materially above 1.0× would provide stronger confirmation that aggressive buyers are controlling the breakout.
Breakout Score: 50 / 100
The supplied model gives BHST a breakout score of 50 / 100.
This represents a moderate breakout setup, rather than a fully confirmed high-quality breakout.
Positive factors include:
- Price above EMA20.
- Price above EMA50.
- Price above EMA100.
- Price above EMA200.
- Price above the $1.70 breakout level.
- CMF near +0.45.
- Strong upward momentum.
- Stage 4 of 5 recovery status.
Main weaknesses include:
- RVOL only around 0.1×.
- RSI is extremely elevated at 83.9.
- Buy / sell ratio only around 1.0×.
- Moving averages are not yet fully arranged in bullish order.
Bottom Score: 25 / 100
BHST has a bottom score of 25 / 100.
The stock previously traded down toward approximately $1.39 before reversing strongly.
The dashboard identifies another recent bottom reference near $1.46.
The current setup is now much more focused on breakout continuation than bottom detection.
Price Structure
The one-minute BHST chart shows a strong reversal structure after the stock traded near the $1.39 area.
Price later recovered toward the $1.50 region, consolidated, and then produced a rapid upside expansion.
The move accelerated through approximately $1.56, $1.60 and eventually the $1.70 breakout level.
The key question now is whether the stock can transform this rapid momentum move into a stable breakout structure.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a biotechnology company focused on Botanical Synthesis.
Its technology platform is designed to produce beneficial plant-based compounds without requiring cultivation of the entire plant.
The company's strategy combines biotechnology, plant-cell science, health and wellness products and commercial development services.
BioHarvest Sciences trades on Nasdaq under the ticker BHST.
Botanical Synthesis Technology
BioHarvest's Botanical Synthesis platform is designed to grow selected plant cells and produce concentrated beneficial compounds under controlled conditions.
Instead of growing the entire plant, the technology focuses on the cells responsible for producing the desired active ingredients.
Potential advantages of this approach include:
- Consistent production conditions.
- Reduced dependency on traditional agriculture.
- Controlled manufacturing.
- Potentially higher concentrations of selected compounds.
- Scalable production of plant-derived molecules.
- Applications across health, nutrition and commercial development.
BioHarvest Business Model
BioHarvest operates across multiple commercial opportunities built around its Botanical Synthesis technology.
The company has developed consumer health products while also expanding its Contract Development and Manufacturing Organization business.
The CDMO model allows outside companies to potentially use BioHarvest's technology for development and production of complex plant-derived molecules.
This creates potential exposure to nutraceutical, nutrition, cosmeceutical and pharmaceutical applications.
VINIA Consumer Product Platform
BioHarvest also markets VINIA, a consumer nutraceutical product derived from its technology platform.
The consumer business provides the company with direct exposure to the health and wellness market.
Growth in consumer sales, repeat customers, new product formats and international expansion could therefore become meaningful business indicators.
Investors should monitor both consumer growth and the development of the company's technology licensing and CDMO opportunities.
Fundamental Checklist
| Factor | What to Monitor |
|---|---|
| Botanical Synthesis | Commercial adoption and validation of the platform. |
| CDMO Business | New development programs, customers and commercial contracts. |
| VINIA | Consumer demand, repeat sales and product expansion. |
| Revenue Growth | Quarterly and annual growth across business divisions. |
| Gross Margin | Manufacturing economics and product profitability. |
| Cash Position | Available liquidity and capital requirements. |
| Operating Expenses | Research, commercialization and manufacturing spending. |
| Partnerships | Commercial and strategic agreements with larger companies. |
| Dilution | Potential future equity financing and share issuance. |
Potential Catalysts
- New Botanical Synthesis commercial contracts.
- New CDMO customers.
- New pharmaceutical or nutrition partnerships.
- Expansion of VINIA sales.
- New consumer-product formats.
- Improved quarterly revenue growth.
- Improved gross margins.
- Improved operating cash flow.
- New industrial applications of Botanical Synthesis.
- Higher institutional interest.
- Higher trading volume.
- RVOL expansion.
- Holding above $1.70.
- Break above $1.75.
- Move toward $1.80.
- Recovery toward the $2.00 region.
Major Risk Factors
- Small-cap stock volatility.
- Extremely elevated RSI.
- Very low relative volume.
- Potential breakout failure.
- Technology commercialization risk.
- Consumer-product demand risk.
- Competition in nutraceutical and biotechnology markets.
- Manufacturing scale-up risk.
- Potential future financing needs.
- Potential shareholder dilution.
- Execution risk in CDMO expansion.
- Rapid momentum reversals.
Bullish Scenario
- BHST holds above $1.70.
- Price breaks $1.73-$1.75.
- RVOL begins to increase.
- CMF remains strongly positive.
- RSI cools without a major price decline.
- Price advances toward $1.80.
- BHST establishes support above $1.80.
- Momentum expands toward $2.00.
The strongest near-term bullish confirmation would be a clean breakout above $1.75 combined with a substantial increase in trading volume.
Neutral / Consolidation Scenario
BHST could consolidate after the sharp move between approximately $1.56 and $1.75.
A consolidation would allow the extremely elevated RSI to cool.
The strongest consolidation structure would maintain the breakout level near $1.70.
A deeper consolidation could test EMA20 and EMA200 near $1.56 without necessarily returning to the major $1.39 low.
Bearish Scenario
The first warning would be a sustained move back below $1.70.
A decline below $1.68 would increase the probability of a deeper pullback.
The next important support zone is approximately $1.56, where EMA20 and EMA200 are located.
Below this region, the EMA50 and EMA100 area near $1.51 would become important.
A larger technical failure could eventually expose $1.46 and the major visible low near $1.39.
Trader's Decision Map
Stronger Setup
Hold $1.70 → break $1.75 → RVOL expands → CMF stays positive → target $1.80 → challenge $2.00.
Wait
Price consolidates between $1.56 and $1.75 while RSI cools and volume improves.
Weak Setup
Lose $1.70 → break $1.68 → test $1.56 → lose $1.51 → potentially move toward $1.46-$1.39.
Potential Trading Plan
- Current Price: $1.73
- Breakout Level: $1.70
- Immediate Resistance: $1.73-$1.75
- Next Resistance: $1.80
- Psychological Resistance: $2.00
- EMA20: $1.56
- EMA200: $1.56
- EMA50: $1.51
- EMA100: $1.51
- Last Bottom: $1.46
- Major Visible Low: $1.39
- Displayed Higher Model Target: $2.34 / $2.43
Dashboard Screening Ratios
The supplied dashboard also displays the following screening values:
- Debt Ratio: 3.38% — displayed in green on the supplied dashboard.
- Liquidity Ratio: 41.37% — displayed in red on the supplied dashboard.
- Interest Ratio: 0.75% — displayed in green on the supplied dashboard.
These labels are reproduced only from the supplied screening dashboard. Investors should independently verify the underlying financial data and the specific Sharia-screening methodology before making any religious or investment determination.
SEO Keywords
Primary Keywords:
BHST stock,
BioHarvest Sciences,
BioHarvest Sciences Inc,
BHST stock analysis,
BHST stock today,
BHST stock price,
BHST stock forecast,
BHST stock prediction,
BioHarvest stock,
NASDAQ BHST.
Technical Analysis Keywords:
BHST technical analysis,
BHST support and resistance,
BHST breakout,
BHST EMA20,
BHST EMA50,
BHST EMA100,
BHST EMA200,
BHST RSI,
BHST RVOL,
BHST CMF,
BHST volume analysis,
BHST price target,
BHST breakout level,
BHST chart analysis.
Company / Sector Keywords:
BioHarvest Botanical Synthesis,
Botanical Synthesis stock,
BioHarvest VINIA,
VINIA stock,
BioHarvest CDMO,
plant biotechnology stock,
nutraceutical stock,
plant cell biotechnology,
BioHarvest technology,
plant molecule technology.
Long-Tail Keywords:
BHST stock analysis today,
BioHarvest Sciences stock analysis,
BHST stock support and resistance,
BHST stock price target,
BHST breakout level,
BHST stock forecast 2026,
BHST technical analysis today,
BHST stock latest analysis,
BioHarvest Sciences stock forecast,
BioHarvest Botanical Synthesis technology.
Final Conclusion
BHST currently shows a powerful short-term technical recovery and has moved above the displayed $1.70 breakout level.
The stock is trading near $1.73 after recovering sharply from the visible chart low near $1.39.
The dashboard places BHST at Stage 4 of 5, with price above EMA20, EMA50, EMA100 and EMA200.
The major EMA support zones are approximately $1.56 and $1.51.
CMF near +0.45 is a major positive factor and indicates strong money flow.
However, RSI near 83.9 shows that short-term momentum is extremely extended.
Relative volume is also weak at approximately 0.1×, which reduces the quality of the breakout confirmation.
The immediate technical battle is now $1.70-$1.75.
A sustained break above $1.75 with stronger volume could open the path toward $1.80 and potentially $2.00.
On the downside, a move back below $1.70 would weaken the breakout.
A deeper correction could test $1.56, followed by the major EMA50/EMA100 support zone near $1.51.
Overall, BHST currently has strong price momentum, positive money flow and a successful move above its initial breakout level, but the extremely high RSI and very low RVOL mean that stronger volume confirmation would significantly improve the technical setup.
Disclaimer: This content is for informational purposes only and does not represent financial advice, a buy recommendation or a sell recommendation.
Available in the USA